167 related articles for article (PubMed ID: 1644934)
1. Cryptosporidiosis in adult and neonatal mice with severe combined immunodeficiency.
Kuhls TL; Greenfield RA; Mosier DA; Crawford DL; Joyce WA
J Comp Pathol; 1992 May; 106(4):399-410. PubMed ID: 1644934
[TBL] [Abstract][Full Text] [Related]
2. Adoptive transfer of immunity with intraepithelial lymphocytes in Cryptosporidium parvum-infected severe combined immunodeficient mice.
Adjei AA; Shrestha AK; Castro M; Enriquez FJ
Am J Med Sci; 2000 Nov; 320(5):304-9. PubMed ID: 11093682
[TBL] [Abstract][Full Text] [Related]
3. Quantification of the infectivity of Cryptosporidium parvum by monitoring the oocyst discharge from SCID mice.
Hikosaka K; Satoh M; Koyama Y; Nakai Y
Vet Parasitol; 2005 Nov; 134(1-2):173-6. PubMed ID: 16076530
[TBL] [Abstract][Full Text] [Related]
4. Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice.
McDonald V; Deer R; Uni S; Iseki M; Bancroft GJ
Infect Immun; 1992 Aug; 60(8):3325-31. PubMed ID: 1639500
[TBL] [Abstract][Full Text] [Related]
5. IL-12 protects immunocompetent and immunodeficient neonatal mice against infection with Cryptosporidium parvum.
Urban JF; Fayer R; Chen SJ; Gause WC; Gately MK; Finkelman FD
J Immunol; 1996 Jan; 156(1):263-8. PubMed ID: 8598471
[TBL] [Abstract][Full Text] [Related]
6. Inability of interferon-gamma and aminoguanidine to alter Cryptosporidium parvum infection in mice with severe combined immunodeficiency.
Kuhls TL; Mosier DA; Abrams VL; Crawford DL; Greenfield RA
J Parasitol; 1994 Jun; 80(3):480-5. PubMed ID: 7515109
[TBL] [Abstract][Full Text] [Related]
7. Differential intra-epithelial lymphocyte phenotypes following Cryptosporidium parvum challenge in susceptible and resistant athymic strains of mice.
Adjei AA; Jones JT; Enriquez FJ
Parasitol Int; 2000 Aug; 49(2):119-29. PubMed ID: 10882901
[TBL] [Abstract][Full Text] [Related]
8. Fulminant cryptosporidiosis associated with digestive adenocarcinoma in SCID mice infected with Cryptosporidium parvum TUM1 strain.
Certad G; Creusy C; Guyot K; Mouray A; Chassat T; Delaire B; Pinon A; Sitja-Bobadilla A; Alvarez-Pellitero P; Praet M; Cuvelier C; Dei-Cas E
Int J Parasitol; 2010 Nov; 40(13):1469-75. PubMed ID: 20708621
[TBL] [Abstract][Full Text] [Related]
9. Interaction of Cryptosporidium parvum and Campylobacter jejuni in experimentally infected neonatal mice.
Vítovec J; Koudela B; Vladík P; Hausner O
Zentralbl Bakteriol; 1991 Jan; 274(4):548-59. PubMed ID: 1863320
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice.
McDonald V; Bancroft GJ
Parasite Immunol; 1994 Jun; 16(6):315-20. PubMed ID: 7970868
[TBL] [Abstract][Full Text] [Related]
11. Effect of surface antigen-1 (SA-1) immune lymphocyte subsets and naive cell subsets in protecting scid mice from initial and persistent infection with Cryptosporidium parvum.
Tatalick LM; Perryman LE
Vet Immunol Immunopathol; 1995 Jul; 47(1-2):43-55. PubMed ID: 8533299
[TBL] [Abstract][Full Text] [Related]
12. Cryptosporidium parvum infection after abrogation of natural killer cell activity in normal and severe combined immunodeficiency mice.
Rohlman VC; Kuhls TL; Mosier DA; Crawford DL; Greenfield RA
J Parasitol; 1993 Apr; 79(2):295-7. PubMed ID: 8459345
[TBL] [Abstract][Full Text] [Related]
13. Cryptosporidium parvum disrupts intestinal epithelial barrier in neonatal mice through downregulation of cell junction molecules.
Luo C; Xu Y; Zhang J; Tian Q; Guo Y; Li N; Feng Y; Xu R; Xiao L
PLoS Negl Trop Dis; 2024 May; 18(5):e0012212. PubMed ID: 38787872
[TBL] [Abstract][Full Text] [Related]
14. Changes in murine intestinal epithelium following Cryptosporidium parvum infection.
Harp JA; Akili D; Pesch BA
J Eukaryot Microbiol; 1999; 46(5):64S-65S. PubMed ID: 10519251
[No Abstract] [Full Text] [Related]
15. Infectivity of Cryptosporidium parvum isolated from asymptomatic adult goats to mice and goat kids.
Noordeen F; Horadagoda NU; Faizal AC; Rajapakse RP; Razak MA; Arulkanthan A
Vet Parasitol; 2002 Jan; 103(3):217-25. PubMed ID: 11750115
[TBL] [Abstract][Full Text] [Related]
16. Neonatal Mouse Gut Metabolites Influence Cryptosporidium parvum Infection in Intestinal Epithelial Cells.
VanDussen KL; Funkhouser-Jones LJ; Akey ME; Schaefer DA; Ackman K; Riggs MW; Stappenbeck TS; Sibley LD
mBio; 2020 Dec; 11(6):. PubMed ID: 33323514
[TBL] [Abstract][Full Text] [Related]
17. Effect of Lactobacillus reuteri on intestinal resistance to Cryptosporidium parvum infection in a murine model of acquired immunodeficiency syndrome.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Adeyemo O
J Infect Dis; 1997 Jan; 175(1):218-21. PubMed ID: 8985225
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis of intestinal crypt epithelium after Cryptosporidium parvum infection.
Sasahara T; Maruyama H; Aoki M; Kikuno R; Sekiguchi T; Takahashi A; Satoh Y; Kitasato H; Takayama Y; Inoue M
J Infect Chemother; 2003 Sep; 9(3):278-81. PubMed ID: 14513402
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.
Alak JI; Wolf BW; Mdurvwa EG; Pimentel-Smith GE; Kolavala S; Abdelrahman H; Suppiramaniam V
Cell Mol Biol (Noisy-le-grand); 1999 Sep; 45(6):855-63. PubMed ID: 10541481
[TBL] [Abstract][Full Text] [Related]
20. Development of Cryptosporidium parvum-induced gastrointestinal neoplasia in severe combined immunodeficiency (SCID) mice: severity of lesions is correlated with infection intensity.
Certad G; Creusy C; Ngouanesavanh T; Guyot K; Gantois N; Mouray A; Chassat T; Flament N; Fleurisse L; Pinon A; Delhaes L; Dei-Cas E
Am J Trop Med Hyg; 2010 Feb; 82(2):257-65. PubMed ID: 20134002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
